Breast/ovarian cancer
101 – 110 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Cancer stem cells and homologous recombination deficiency in serous ovarian and endometrial carcinoma
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
- Contribution to journal › Article
-
Mark
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated with Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor) : A Report of 22 Cases
- Contribution to journal › Article
-
Mark
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
- Contribution to journal › Article
-
Mark
Breast cancer risk genes - Association analysis in more than 113,000 women
- Contribution to journal › Article
- 2020
-
Mark
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
- Contribution to journal › Article
-
Mark
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
- Contribution to journal › Article
